130 related articles for article (PubMed ID: 21751529)
1. [IDH mutation on glioma].
Mukasa A
Gan To Kagaku Ryoho; 2011 Jun; 38(6):937-40. PubMed ID: 21751529
[No Abstract] [Full Text] [Related]
2. IDH1 mutations in gliomas: when an enzyme loses its grip.
Frezza C; Tennant DA; Gottlieb E
Cancer Cell; 2010 Jan; 17(1):7-9. PubMed ID: 20129244
[TBL] [Abstract][Full Text] [Related]
3. Glioma-derived mutations in IDH: from mechanism to potential therapy.
Fu Y; Huang R; Du J; Yang R; An N; Liang A
Biochem Biophys Res Commun; 2010 Jun; 397(2):127-30. PubMed ID: 20510884
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance metabolic imaging of glioma.
Metellus P; Figarella-Branger D
Sci Transl Med; 2012 Jan; 4(116):116ps1. PubMed ID: 22238331
[TBL] [Abstract][Full Text] [Related]
5. Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas.
Weller M; Wick W; von Deimling A
Glia; 2011 Aug; 59(8):1200-4. PubMed ID: 21294161
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.
Schittenhelm J; Mittelbronn M; Meyermann R; Melms A; Tatagiba M; Capper D
Acta Neuropathol; 2011 Nov; 122(5):651-2. PubMed ID: 21983902
[No Abstract] [Full Text] [Related]
7. IDH1 and IDH2 mutations in gliomas.
Ducray F; Marie Y; Sanson M
N Engl J Med; 2009 May; 360(21):2248-9; author reply 2249. PubMed ID: 19469031
[No Abstract] [Full Text] [Related]
8. Glioma IDH1 mutation patterns off the beaten track.
Pusch S; Sahm F; Meyer J; Mittelbronn M; Hartmann C; von Deimling A
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):428-30. PubMed ID: 20874727
[No Abstract] [Full Text] [Related]
9. IDH mutations in glioma and acute myeloid leukemia.
Dang L; Jin S; Su SM
Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
[TBL] [Abstract][Full Text] [Related]
10. Isocitrate dehydrogenase mutations may be a protective mechanism in glioma patients.
Zhu J; Zuo J; Xu Q; Wang X; Wang Z; Zhou D
Med Hypotheses; 2011 Apr; 76(4):602-3. PubMed ID: 21284999
[TBL] [Abstract][Full Text] [Related]
11. Role of isocitrate dehydrogenase in glioma.
Alexander BM; Mehta MP
Expert Rev Neurother; 2011 Oct; 11(10):1399-409. PubMed ID: 21955197
[TBL] [Abstract][Full Text] [Related]
12. IDH mutation in glioma: molecular mechanisms and potential therapeutic targets.
Han S; Liu Y; Cai SJ; Qian M; Ding J; Larion M; Gilbert MR; Yang C
Br J Cancer; 2020 May; 122(11):1580-1589. PubMed ID: 32291392
[TBL] [Abstract][Full Text] [Related]
13. Two Unique Glioma Subtypes Revealed.
Poh A
Cancer Discov; 2016 Apr; 6(4):334-5. PubMed ID: 26917670
[TBL] [Abstract][Full Text] [Related]
14. IDH mutations in human glioma.
Kim W; Liau LM
Neurosurg Clin N Am; 2012 Jul; 23(3):471-80. PubMed ID: 22748659
[TBL] [Abstract][Full Text] [Related]
15. In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists.
Kim H; Kim S; Lee HH; Heo H
Korean J Radiol; 2016; 17(5):620-32. PubMed ID: 27587950
[TBL] [Abstract][Full Text] [Related]
16. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
Louis DN; Giannini C; Capper D; Paulus W; Figarella-Branger D; Lopes MB; Batchelor TT; Cairncross JG; van den Bent M; Wick W; Wesseling P
Acta Neuropathol; 2018 Apr; 135(4):639-642. PubMed ID: 29497819
[No Abstract] [Full Text] [Related]
17. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.
Kickingereder P; Sahm F; Radbruch A; Wick W; Heiland S; Deimling Av; Bendszus M; Wiestler B
Sci Rep; 2015 Nov; 5():16238. PubMed ID: 26538165
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of nondiagnostic biopsies of suspected low-grade glioma using isocitrate dehydrogenase 1 mutation immunohistochemistry.
Anderson MD; Abel TW; Moots PL
Neuro Oncol; 2013 Jul; 15(7):811-3. PubMed ID: 23737489
[No Abstract] [Full Text] [Related]
19. Correspondence regarding: diagnostic utility of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 2009:68;1319-25.
Wiwanitkit V
J Neuropathol Exp Neurol; 2010 Mar; 69(3):320; author reply 320-1. PubMed ID: 20190607
[No Abstract] [Full Text] [Related]
20. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]